Phase I Study of TH1 Dendritic Cell Immunotherapy for the Treatment of Cutaneous Angiosarcoma
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Amgen
M.D. Anderson Cancer Center
University of Oklahoma
City of Hope Medical Center
Amgen
National Institutes of Health Clinical Center (CC)